The night sky over the Atacama desert was a black canvas punctuated by a thousand indifferent stars. In a weather‑worn container of solar panels and blinking LEDs, Dr. Maya Larkin stared at a stream of numbers scrolling across her laptop. The pattern was too regular to be noise, too precise to be a random glitch. It was a sequence that repeated every 37.2 seconds, a pulse that seemed to be trying—almost pleading—to be heard.
Without specific details, here's a general approach to finding a complete paper: JUQ-934
Because the compound is still pre‑clinical, most of the data available are from in‑vitro assays, cell‑based pharmacology, and early animal efficacy studies. This review collates all publicly accessible information, critically evaluates the current state of knowledge, and outlines the key questions that must be addressed before JUW‑934 can advance to human trials. The night sky over the Atacama desert was
| Property | Value | |----------|-------| | | 3‑[(4‑fluorophenyl)amino]‑2‑[(1‑methyl‑1H‑imidazol‑5‑yl)methyl]‑5‑(trifluoromethyl)‑1,4‑dihydro‑pyridine‑6‑carboxamide | | Synonyms | JUQ‑934; 4‑F‑BETA‑3; PTC‑938 | | Molecular formula | C₁₈H₁₈F₄N₅O | | Molecular weight | 387.33 g·mol⁻¹ | | SMILES | CC1=CN(C=N1)CCc2cnc(Nc3ccc(F)cc3)nc2C(F)(F)F | | InChIKey | XJXKZVQWZKYJGT-UHFFFAOYSA-N | | Physical state | White crystalline solid; soluble in DMSO, moderately soluble in 0.5 % methylcellulose (pH 7.4) | | pKa (predicted) | 7.6 (basic imidazole) | | LogP (XlogP3-AA) | 3.1 (moderately lipophilic) | The pattern was too regular to be noise,